Clinical Trials Logo

Non-small-lung-cell Cancer clinical trials

View clinical trials related to Non-small-lung-cell Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT04552613 Completed - NSCLC Clinical Trials

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

Start date: November 23, 2020
Phase: N/A
Study type: Interventional

This study is a randomized, multicenter clinical study ,which is designed to compare the efficacy of the safety and efficacy of treatment every 6 weeks in EGFR positive (Non-small cell lung cancer, NSCLC) with concurrent Driver gene mutations,who used EGFR-TKI with or without combined chemotherapy,estimated with stable efficacy (CR, PR, and SD) .In this study, subjects will be randomly assigned to the following two groups according to a 1:1 ratio:(A) Standard programme group, EGFR-TKI targeted therapy; (B) controlled programme group, EGFR-TKI targeted therapy combined chemotherapy(pemetrexed plus carboplatin for 4 cycles )